10 - A) ANTIDEPRESSANT DRUGS Flashcards
TREATMENT OF DEPRESSION
- Psychotherapy
- Medication
1st choice: SSRIs or TCAs depending on patient’s characteristics
↑ Tendency to use new antidepressants
MIRTAZAPINE
VENLAFAXINE…
Controversy
2, Electroconvulsive therapy
MIRTAZAPINE
Treatment of depression; ventlafaxine and mirtazapine have a high conrovery.
Antagonist of alpha-2 adrenergic receptors
MIANSERIN
VENLAFAXINE
Treatment of depression; ventlafaxine and mirtazapine have a high conrovery.
CLASSIFICATION OF ANTIDEPRESSANT DRUGS
Monoamine reuptake inhibitors
Monoaminoxidase inhibitorrs (MAOIs)
Other
MONOAMINE REUPTAKE INHIBITORS
. Monoamine reuptake inhibitors
2.1.1. Non selective inhibitors: Tricyclic Antidepressants: TCAs
IMIPRAMINE, DESIMIPRAMINE, AMITRIPTYLINE, NORTRIPTYLINE, DOXEPIN
2.1.2. Selective Serotonin Reuptake Inhibitors: SSRIs
FLUOXETINE, PAROXETINE, CITALOPRAM, ESCITALOPRAM, SERTRALINE
2.1.3. NA Reuptake Inhibitors: NRIs REBOXETINE
2.1.4. 5-HT/NA Reuptake Inhibitors de: SNRIs
VENLAFAXINE, DULOXETINE
2.1.5. DA & NA Reuptake Inhibitors: BUPROPION
MONOAMINOXIDASE INHIBITORS (MAOIs)
- 2.1. Irreversible non-selective: TRANYLCYPROMINE
2. 2.2. Reversible MAO-A Inhibitors: MOCLOBEMIDE (RMAIs)
OTHERS
Antagonists of α2-adrenergic receptors: MIRTAZAPINE, MIANSERIN
Melatonin receptor agonists, 5HT2 Antagonists?
Phytotherapy: Hypericum (St John’s-wort)
Non selective inhibitors: Tricyclic Antidepressants: TCAs
Antidepressant drugs. Monoamine reuptake drugs (Al igual que los MAOIs and others). IMIPRAMINE DESIMIPRAMINE AMITRIPTYLINE NORTRIPTYLINE DOXEPIN
They act by blocking the reuptae of NA and 5-TH, by competing with its transporter. They inhibit DA reuptake too, but in lesser extent.
TCAs block adrenoceptors α1, muscarinic & histaminic receptors; producing ADVERSE REACTIONS.
IMIPRAMINE
Antidepressant drugs. Monoamine reuptake drugs (Al igual que los MAOIs and others). IMIPRAMINE DESIMIPRAMINE AMITRIPTYLINE NORTRIPTYLINE DOXEPIN
DESIMIPRAMINE
Antidepressant drugs. Monoamine reuptake drugs (Al igual que los MAOIs and others). IMIPRAMINE DESIMIPRAMINE AMITRIPTYLINE NORTRIPTYLINE DOXEPIN
AMITRIPTYLINE
Antidepressant drugs. Monoamine reuptake drugs (Al igual que los MAOIs and others). Its the safest. IMIPRAMINE DESIMIPRAMINE AMITRIPTYLINE NORTRIPTYLINE DOXEPIN
NORTRIPTYLINE
Antidepressant drugs. Monoamine reuptake drugs (Al igual que los MAOIs and others). IMIPRAMINE DESIMIPRAMINE AMITRIPTYLINE NORTRIPTYLINE DOXEPIN
DOXEPIN
Antidepressant drugs. Monoamine reuptake drugs (Al igual que los MAOIs and others). IMIPRAMINE DESIMIPRAMINE AMITRIPTYLINE NORTRIPTYLINE DOXEPIN
Non selective inhibitors: Tricyclic Antidepressants: TCAs. -> PHARMACOLOGICAL ACTIONS
In not depressed people: Sedation, confusion, loss of motor coordination
• In depressed patients: tend to disappear in 10-15 days
- Antidepressant Action (10-15days) Do not produce CNS stimulation
- Anti-anxiety and Sedative Action
- Analgesic Action
ADVERSE REACTIONS DEPENDING ON WHICH TRANSPORTER IS INHIBITED (TCAs)
Numerous NORTRIPTYLINE is safer
- By (-) reuptake NA: tachycardia, tremor, anxiety
- By (-) reuptake 5-HT: nausea
- By H1 blockade: Sedation, lack of concentration…
- By muscarinic blockade: Blurred vision, constipation, urinary retention
- By α1 blockade: Orthostatic hypotension
- By K+ channel blockade: CARDIOTOXICITY:Arrhythmias, altered contractility,
altered frequency…
At normal doses, increase the risk of sudden cardiac death
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS (Drugs)
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS
FLUOXETINE (Prozac) “happiness pill”
PAROXETINE (Serotax) (most potent)
CITALOPRAM (Seropram) (most selective)
ESCITALOPRAM (Cipralex ) ((S)-stereoisomer (Left-enantiomer) of citalopram)
SERTRALINE (also inhibits reuptake of DA)
FLUOXETINE
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS
FLUOXETINE (Prozac) “happiness pill”
PAROXETINE (Serotax) (most potent)
CITALOPRAM (Seropram) (most selective)
ESCITALOPRAM (Cipralex ) ((S)-stereoisomer (Left-enantiomer) of citalopram)
SERTRALINE (also inhibits reuptake of DA)
PAROXETINE
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS
FLUOXETINE (Prozac) “happiness pill”
PAROXETINE (Serotax) (most potent)
CITALOPRAM (Seropram) (most selective)
ESCITALOPRAM (Cipralex ) ((S)-stereoisomer (Left-enantiomer) of citalopram)
SERTRALINE (also inhibits reuptake of DA)
CITALOPRAM
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS
FLUOXETINE (Prozac) “happiness pill”
PAROXETINE (Serotax) (most potent)
CITALOPRAM (Seropram) (most selective)
ESCITALOPRAM (Cipralex ) ((S)-stereoisomer (Left-enantiomer) of citalopram)
SERTRALINE (also inhibits reuptake of DA)
ESCITALOPRAM
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS
FLUOXETINE (Prozac) “happiness pill”
PAROXETINE (Serotax) (most potent)
CITALOPRAM (Seropram) (most selective)
ESCITALOPRAM (Cipralex ) ((S)-stereoisomer (Left-enantiomer) of citalopram)
SERTRALINE (also inhibits reuptake of DA)
SERTRALINE
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS
FLUOXETINE (Prozac) “happiness pill”
PAROXETINE (Serotax) (most potent)
CITALOPRAM (Seropram) (most selective)
ESCITALOPRAM (Cipralex ) ((S)-stereoisomer (Left-enantiomer) of citalopram)
SERTRALINE (also inhibits reuptake of DA)
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS (Mechanism of action and pharmacological interactions )
Selective blockade of 5-HT reuptake transporters.
1 - Antidepressant Action: moderate (2-4 weeks)
Do not produce CNS stimulation
2- Anti-anxiety Action: Effective in panic attack, phobia, bulimia,
obsessive-compulsive disorder…
Depression + Insomnia Treatment
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS (Adverse effects)
Adverse Reactions: less than TCAs (< effect on NA)
- Nausea, vomits, anorexia, insomnia, sexual dysfunction, hyponatremia, ↑weight
Selective inhibitors: SEROTONIN REUPTAKE INHIBITORS (Interactions)
Interactions:
- They are enzymatic inhibitors: metabolism TCAs (avoid)
- “Serotoninergic Syndrome”: (+ MAOIs, tryptophan or lithium).
Tremor
Hyperthermia
Agitation
- “Withdrawal Syndrome”: malaise, chills, nausea,
unbalance, anxiety, irritability
Selective inhibitors:NORADRENALINE REUPTAKE INHIBITORS (NRIs)
Roboxetine
Selective inhibitors: SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs)
VENLAFAXINE, DULOXETINE
structure different to TCAs
Selective inhibitors: DOPAMINE AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs)
Buproprion, used for depression and tobacco cessation.
MONOAMINE OXIDASE INHIBITORS (MAOIs)
Main enzymes
MAO-A: preferent substrates
5-HT, DA, NA …
MAO-B: preferent substrates
phenylethylamine,DA, NA
Antidepressant effect related to
MAO-A inhibition
Monoaminoxidase Inhibitors (MAOIs) Irreversible non-selective (classic) (Drug)
TRANYLCYPROMINE
TRANYLCYPROMINE (Mechanism of action, pharmacological actions and adverse reactions)
Monoaminoxidase Inhibitors (MAOIs) Irreversible non-selective (classic) (Drug)
Mechanism of action:
Non-competitive long lasting binding to MAO-A & MAO-B ; maintained effect until regeneration of new enzyme (≅ 2 weeks)
Pharmacological Actions:
• In not depressed people: euphoria, excitement and increased motor activity
• In depressed patients: Suppression of ideas and feelings of depression
Adverse Reactions:
Excessive central stimulation (tremor, insomnia, excitement):
≅ AMPHETAMINE stimulus
MAO Inhibition; increases endogenous vasopressor amines; hypertensive crisis may appear
Sometimes hypotension due to displacement and emptying of NA from vesicles
TRANYLCYPROMINE (Interactions)
• HYPERTENSIVE CRISIS:
Increased effects of indirect and mixed sympathomimetic agents
Incresed exogenous amines (some substrate of MAO)
- levodopa, TCAs, cocaine, amphetamines,
nasal decongestants …
- foods rich in tyramine (fermented cheese, cured meat…)
“cheese reaction”
EXACERBATION OF SYMPATHOMIMETIC EFFECTS
• SEROTONINERGIC SYNDROME:
sweating, chills, tremor, ataxia, seizures, disorientation…
MAOIs + TCAs MAOIs + SSRIs
Moclobemine
Reversible MOA - A- Inhibitors (RMAIs)
Less Adverse Reactions
Less interactions
No cheese reaction
Antagonists of α2-adrenergic receptors (presynaptic). Drugs and mechanism of action
MIRTAZAPINE, MIANSERIN
α2-adrenergic R activation inhibits release of NA & 5HT α2-adrenergic R blockade increases release of NA & 5HT